IPP Bureau
Zydus’ OxemiaTM receives approval from DCGI to treat Anaemia associated with Chronic Kidney Disease
By IPP Bureau - March 07, 2022
OxemiaTM (Desidustat) is an oral tablet formulation that is the first-in-India alternative to injectable erythropoietin-stimulating agents (ESAs)
Thermo Fisher Scientific unveils new genetic analyzer
By IPP Bureau - March 07, 2022
Expanding the Applied Biosystems portfolio with the latest generation of innovative, mid-throughput genetic analyzers
Jardiance is first and only treatment approved in Europe for chronic heart failure
By IPP Bureau - March 07, 2022
The breakthrough approval expands the existing indication of Jardiance to include adults with heart failure with preserved ejection fraction (HFpEF), an underserved patient population that previously had no approved therapies in Europe
AstraZeneca flags off ‘AZ Forest’ a mass sapling plantation campaign in Bengaluru
By IPP Bureau - March 07, 2022
Commits to plant 5000 trees in phase 1 with its partner SankalpTaru Foundation
Medtronic launches device to simplify type 1 diabetes management
By IPP Bureau - March 07, 2022
First advanced hybrid closed-loop insulin pump system in India features automatic insulin delivery, automatic correction boluses, and bluetooth connectivity
Evonik invests in US-based 3D screen printing technology firm Laxxon Medical
By IPP Bureau - March 07, 2022
Laxxon Medical has developed a 3D screen printing technology for the manufacture of structured tablets that enables the controlled release of active pharmaceutical ingredients over time
Arctoris and Evariste Technologies form JV to treat non-small cell lung cancer
By IPP Bureau - March 07, 2022
Arctoris and Evariste Technologies announce a joint venture to develop novel small molecule kinase inhibitors for non-small cell lung cancer (NSCLC)
Elixirgen Therapeutics and Taisho Pharmaceutical tie-up to cure ageing-associated diseases
By IPP Bureau - March 07, 2022
Taisho Pharmaceutical will bring its experience and expertise in the research and development of therapeutic products to the collaboration.
Bone Biologics enters into supply agreement with MTF Biologics for demineralized bone matrix
By IPP Bureau - March 07, 2022
This supply agreement provides material for the company’s planned 30-patient pilot study, and later for its planned U.S. pivotal study in spine fusion patients
Lupin signs Mary Kom for its Shakti campaign promoting heart health
By IPP Bureau - March 07, 2022
The initiative brings internationally eminent cardiologists to increase awareness of health screening tests amongst pre-menopausal women
NATCO launches first generic version of Revlimid in the US
By IPP Bureau - March 07, 2022
NATCO and Teva are launching these strengths of lenalidomide pursuant to a license of patents owned by Celgene
Aurobindo Pharma Foundation dedicates mini-lift irrigation scheme
By IPP Bureau - March 06, 2022
With the implementation of this project, a total of 1,030 acres of cultivable land can be irrigated per crop cycle
Kilitch Drugs earmarks Rs. 100 crore as part of its expansion
By IPP Bureau - March 06, 2022
The company plans to establish a state-of-the-art greenfield pharma facility with a total of 4-6 manufacturing units in different therapeutics categories to cater to domestic and export markets
Datar Cancer Genetics partners with Kokilaben Hospital to offer advanced cancer tests
By IPP Bureau - March 06, 2022
A simple blood test detects over 30 types of cancers
USFDA approves expanded use of Bristol Myers Opdivo
By IPP Bureau - March 06, 2022
The approval marks the first-and-only immunotherapy-based treatment for use before surgery for non-small cell lung cancer
